Correction: Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors (Proceedings of the National Academy of Sciences (2019) 116 (619-624) DOI: 10.1073/pnas.1814027116)Charles Li,Elena Bonazzoli,Stefania Bellone,Jungmin Choi,Weilai Dong,Gulden Menderes,Gary Altwerger,Chanhee Han,Aranzazu Manzano,Anna Bianchi,Francesca Pettinella,Paola Manara,Salvatore Lopez,Ghanshyam Yadav,Francesco Riccio,Luca Zammataro,Burak Zeybek, Yang Yang-Hartwich,Natalia Buza,Pei Hui,Serena Wong,Antonella Ravaggi,Eliana Bignotti,Chiara Romani,Paola Todeschini,Laura Zanotti,Valentina Zizioli,Franco Odicino,Sergio Pecorelli,Laura Ardighieri,Dan-Arin Silasi,Babak Litkouhi,Elena Ratner,Masoud Azodi,Gloria S. Huang,Peter E. Schwartz,Richard P. Lifton,Joseph Schlessinger,Alessandro D. SantinProceedings of the National Academy of Sciences of the United States of America(2019)引用 1|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要